Retinoid-lipid drug carrier
US10196637B2 · kind B2 · utility
3Cited by
51References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 3, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Oct 3, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
What is described is a pharmaceutical composition for treating a fibrotic disease comprising a drug carrier, which comprises a lipid and a retinoid, and a double-stranded nucleic acid molecule, which comprises an antisense sequence to mRNA encoding human hsp47.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.